1990
DOI: 10.1159/000150162
|View full text |Cite
|
Sign up to set email alerts
|

Cross-Reactivity with SIVmac in East African HIV-1-Positive Sera: Evidence against Double Infection with HIV-1 and a SIVmac/HIV-2-like Virus

Abstract: IgG antibodies reactive with simian immunodeficiency virus isolated from a rhesus monkey suffering from simian acquired immunodeficiency syndrome (SIVmac, strain 239, a virus which is very closely related to human immunodeficiency virus type 2-HIV-2) were found in 18 of 120 Swedish and 8 of 11 east African confirmed HIV-1 antibody positive (HIV-1 ab + ) sera, both by enzyme immunoassay and electrophoretic immunoblotting (p = 1 × 10 6). In electrophoretic immunoblotting most of the cross-reactivity o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2000
2000

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…However, the use of [MLV(HIV-1)] in HIV-seropositive individuals is hampered by the presence of antibodies directed against HIV-1 envelope proteins, which are expected to significantly reduce transduction efficiencies. Although neutralization of [MLV(SIVmac)] vector particles by HIV-1-specific antibodies was not studied by Indraccolo et al (1998), it is known from previous reports that sera from HIV-1-infected individuals cross-react with SIVmac (Blomberg et al, 1990). In contrast, the simian immunodeficiency virus (SIVagm) from African green monkeys (Chlorocebus pygerythrus) is only poorly neutralized by HIV-1-specific antibodies (Cichutek and Norley, 1993).…”
Section: Introductionmentioning
confidence: 99%
“…However, the use of [MLV(HIV-1)] in HIV-seropositive individuals is hampered by the presence of antibodies directed against HIV-1 envelope proteins, which are expected to significantly reduce transduction efficiencies. Although neutralization of [MLV(SIVmac)] vector particles by HIV-1-specific antibodies was not studied by Indraccolo et al (1998), it is known from previous reports that sera from HIV-1-infected individuals cross-react with SIVmac (Blomberg et al, 1990). In contrast, the simian immunodeficiency virus (SIVagm) from African green monkeys (Chlorocebus pygerythrus) is only poorly neutralized by HIV-1-specific antibodies (Cichutek and Norley, 1993).…”
Section: Introductionmentioning
confidence: 99%